Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence A Donehower

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Disease Models & Mechanisms|February 17, 2022
K-Ras and p53 mouse model with molecular characteristics of human rhabdomyosarcoma and translational applicationsKengo Nakahata, Brian W Simons, Enrico Pozzo, et al.
Cancer Research|March 12, 2009
MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progressionOu Ma, Wei-Wen Cai, Lars Zender, et al.
Molecular and Cellular Biology|January 26, 2002
Mice deficient for the wild-type p53-induced phosphatase gene (Wip1) exhibit defects in reproductive organs, immune function, and cell cycle controlJene Choi, Bonnie Nannenga, Oleg N Demidov, et al.
Journal of Neuro-Oncology|October 13, 2007
Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1DRobert C Castellino, Massimiliano De Bortoli, Xiongbin Lu, et al.
The Journal of Pathology|August 18, 2012
MLH1-silenced and non-silenced subgroups of hypermutated colorectal carcinomas have distinct mutational landscapesLawrence A Donehower, Chad J Creighton, Nikolaus Schultz, et al.
The EMBO Journal|March 3, 2006
Oncogenic function for the Dlg1 mammalian homolog of the Drosophila discs-large tumor suppressorKristopher K Frese, Isabel J Latorre, Sang-Hyuk Chung, et al.
Breast Cancer Research and Treatment|December 31, 2010
P53 genotype as a determinant of ER expression and tamoxifen response in the MMTV-Wnt-1 model of mammary carcinogenesisRobin Fuchs-Young, Stephanie H Shirley, Isabel Lambertz, et al.
Cell Reports|August 1, 2019
Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome AtlasLawrence A Donehower, Thierry Soussi, Anil Korkut, et al.
Cancer Cell|September 10, 2014
Notch activation as a driver of osteogenic sarcomaJianning Tao, Ming-Ming Jiang, Lichun Jiang, et al.
Cancer Research|August 4, 2004
Loss of heterozygosity occurs via mitotic recombination in Trp53+/- mice and associates with mammary tumor susceptibility of the BALB/c strainAnneke C Blackburn, S Christine McLary, Rizwan Naeem, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Disease Models & Mechanisms|February 17, 2022
K-Ras and p53 mouse model with molecular characteristics of human rhabdomyosarcoma and translational applicationsKengo Nakahata, Brian W Simons, Enrico Pozzo, et al.
Cancer Research|March 12, 2009
MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progressionOu Ma, Wei-Wen Cai, Lars Zender, et al.
Molecular and Cellular Biology|January 26, 2002
Mice deficient for the wild-type p53-induced phosphatase gene (Wip1) exhibit defects in reproductive organs, immune function, and cell cycle controlJene Choi, Bonnie Nannenga, Oleg N Demidov, et al.
Journal of Neuro-Oncology|October 13, 2007
Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1DRobert C Castellino, Massimiliano De Bortoli, Xiongbin Lu, et al.
The Journal of Pathology|August 18, 2012
MLH1-silenced and non-silenced subgroups of hypermutated colorectal carcinomas have distinct mutational landscapesLawrence A Donehower, Chad J Creighton, Nikolaus Schultz, et al.
The EMBO Journal|March 3, 2006
Oncogenic function for the Dlg1 mammalian homolog of the Drosophila discs-large tumor suppressorKristopher K Frese, Isabel J Latorre, Sang-Hyuk Chung, et al.
Breast Cancer Research and Treatment|December 31, 2010
P53 genotype as a determinant of ER expression and tamoxifen response in the MMTV-Wnt-1 model of mammary carcinogenesisRobin Fuchs-Young, Stephanie H Shirley, Isabel Lambertz, et al.
Cell Reports|August 1, 2019
Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome AtlasLawrence A Donehower, Thierry Soussi, Anil Korkut, et al.
Cancer Cell|September 10, 2014
Notch activation as a driver of osteogenic sarcomaJianning Tao, Ming-Ming Jiang, Lichun Jiang, et al.
Cancer Research|August 4, 2004
Loss of heterozygosity occurs via mitotic recombination in Trp53+/- mice and associates with mammary tumor susceptibility of the BALB/c strainAnneke C Blackburn, S Christine McLary, Rizwan Naeem, et al.
Pageof 10